4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001209191-23-024125
Options or other derivatives
- Chief Financial Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ballantyne Charles Evan Chief Financial Officer | 2023-04-10 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
| Ballantyne Charles Evan Chief Financial Officer | 2023-04-10 | Grant or award · Restricted Stock Units | +50,000 | 50,000 | D | ||
Loading xslF345X04/doc4.xml…